The use of aprotinin in children undergoing operative repair of isolated atrial septal defects
dc.contributor.author | Chiravuri, Srinivas Devi. | en_US |
dc.contributor.author | Voepel-Lewis, Terri | en_US |
dc.contributor.author | Devaney, Eric J. | en_US |
dc.contributor.author | Malviya, Shobha | en_US |
dc.date.accessioned | 2010-06-01T21:07:56Z | |
dc.date.available | 2010-06-01T21:07:56Z | |
dc.date.issued | 2008-02 | en_US |
dc.identifier.citation | CHIRAVURI, S. DEVI; VOEPEL-LEWIS, TERRI; DEVANEY, ERIC J.; MALVIYA, SHOBHA (2008). "The use of aprotinin in children undergoing operative repair of isolated atrial septal defects." Pediatric Anesthesia 18(2): 145-150. <http://hdl.handle.net/2027.42/74215> | en_US |
dc.identifier.issn | 1155-5645 | en_US |
dc.identifier.issn | 1460-9592 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74215 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18184246&dopt=citation | en_US |
dc.format.extent | 78349 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2007 The Authors Journal compilation 2007 Blackwell Publishing Ltd | en_US |
dc.subject.other | Aprotinin | en_US |
dc.subject.other | Children | en_US |
dc.subject.other | Atrial Septal Defect | en_US |
dc.subject.other | Cardiopulmonary Bypass | en_US |
dc.subject.other | Transfusion | en_US |
dc.title | The use of aprotinin in children undergoing operative repair of isolated atrial septal defects | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 18184246 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74215/1/j.1460-9592.2007.02361.x.pdf | |
dc.identifier.doi | 10.1111/j.1460-9592.2007.02361.x | en_US |
dc.identifier.source | Pediatric Anesthesia | en_US |
dc.identifier.citedreference | Arnold DM, Fergusson DA, Chan AK et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006; 102: 731 – 737. | en_US |
dc.identifier.citedreference | Henry DA, Moxey AJ, Carless PA et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 3, 2007. | en_US |
dc.identifier.citedreference | Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004; 128: 442 – 448. | en_US |
dc.identifier.citedreference | Mangano DT, Tudor IC, Dietzel C et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353 – 365. | en_US |
dc.identifier.citedreference | Karkouti K, Beattie WS, Dattilo KM et al. A propensity score case–control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006; 46: 327 – 338. | en_US |
dc.identifier.citedreference | Mangano DT, Miao Y, Vuylsteke A et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297: 471 – 479. | en_US |
dc.identifier.citedreference | Boldt J, Knothe C, Zickmann B et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss (see comment). J Thorac Cardiovasc Surgery 1993; 105: 705 – 711. | en_US |
dc.identifier.citedreference | D’Errico CC, Shayevitz JR, Martindale SJ et al. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 1996; 83: 1193 – 1199. | en_US |
dc.identifier.citedreference | Herynkopf F, Lucchese F, Pereira E et al. Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study. J Thorac Cardiovasc Surg 1994; 108: 517 – 521. | en_US |
dc.identifier.citedreference | Mossinger H, Dietrich W, Braun SL et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003; 75: 430 – 437. | en_US |
dc.identifier.citedreference | Kern FH, Morana NJ, Sears JJ et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 541 – 546. | en_US |
dc.identifier.citedreference | Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion 1991; 6: 41 – 650. | en_US |
dc.identifier.citedreference | Levy JH. Hemostatic agents and their safety. J Cardiothorac Vasc Anesth 1999; 13: 6 – 11. | en_US |
dc.identifier.citedreference | Dietrich W. Incidence of hypersensitivity reactions. Ann Thorac Surg 1998; 65: S60 – S64. | en_US |
dc.identifier.citedreference | Cohen DM, Norberto J, Cartabuke R et al. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg 1999; 67: 837 – 838. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.